Abstract
Although the fact that genetic predisposition and environmental exposures interact to shape development and function of the human brain and, ultimately, the risk of psychiatric disorders has drawn wide interest, the corresponding molecular mechanisms have not yet been elucidated. We found that a functional polymorphism altering chromatin interaction between the transcription start site and long-range enhancers in the FK506 binding protein 5 (FKBP5) gene, an important regulator of the stress hormone system, increased the risk of developing stress-related psychiatric disorders in adulthood by allele-specific, childhood trauma–dependent DNA demethylation in functional glucocorticoid response elements of FKBP5. This demethylation was linked to increased stress-dependent gene transcription followed by a long-term dysregulation of the stress hormone system and a global effect on the function of immune cells and brain areas associated with stress regulation. This identification of molecular mechanisms of genotype-directed long-term environmental reactivity will be useful for designing more effective treatment strategies for stress-related disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Accession codes
References
Caspi, A. & Moffitt, T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 7, 583–590 (2006).
Caspi, A., Hariri, A.R., Holmes, A., Uher, R. & Moffitt, T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 167, 509–527 (2010).
Binder, E.B. et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. J. Am. Med. Assoc. 299, 1291–1305 (2008).
Heim, C. et al. Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene. Front. Behav. Neurosci. 3, 41 (2009).
Xie, P. et al. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder 3. Neuropsychopharmacology 35, 1684–1692 (2010).
Pratt, W.B. & Toft, D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306–360 (1997).
Binder, E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34 (suppl. 1), S186–S195 (2009).
Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477–501 (2000).
Heim, C., Newport, D.J., Mletzko, T., Miller, A.H. & Nemeroff, C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33, 693–710 (2008).
Scammell, J.G., Denny, W.B., Valentine, D.L. & Smith, D.F. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen. Comp. Endocrinol. 124, 152–165 (2001).
Wochnik, G.M. et al. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 280, 4609–4616 (2005).
Jääskeläinen, T., Makkonen, H. & Palvimo, J.J. Steroid up-regulation of FKBP51 and its role in hormone signaling 4. Curr. Opin. Pharmacol. 11, 326–331 (2011).
Appel, K. et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 36, 1982–1991 (2011).
Koenen, K.C. et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol. Psychiatry 10, 1058–1059 (2005).
Mehta, D. et al. Using polymorphisms in FKBP5 to define biologically distinct subtypes of post-traumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 68, 901–910 (2011).
Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D. & Enoch, M.A. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35, 1674–1683 (2010).
Zimmermann, P. et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am. J. Psychiatry 168, 1107–1116 (2011).
Binder, E.B. et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment 45. Nat. Genet. 36, 1319–1325 (2004).
1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).
Paakinaho, V., Makkonen, H., Jaaskelainen, T. & Palvimo, J.J. Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol. Endocrinol. 24, 511–525 (2010).
Ising, M. et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur. J. Neurosci. 28, 389–398 (2008).
McGowan, P.O. et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342–348 (2009).
Murgatroyd, C. et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress 8. Nat. Neurosci. 12, 1559–1566 (2009).
Weaver, I.C. et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847–854 (2004).
Thomassin, H., Flavin, M., Espinas, M.L. & Grange, T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 20, 1974–1983 (2001).
Lee, R.S. et al. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 151, 4332–4343 (2010).
Pace, T.W. et al. Increased peripheral NF-kappaB pathway activity in women with childhood abuse-related post-traumatic stress disorder. Brain Behav. Immun. 26, 13–17 (2011).
Sommershof, A. et al. Substantial reduction of naive and regulatory T cells following traumatic stress 1. Brain Behav. Immun. 23, 1117–1124 (2009).
Anacker, C. et al. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol. Psychiatry 16, 738–750 (2011).
Klug, M. & Rehli, M. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 1, 127–130 (2006).
Kelder, T. et al. Mining biological pathways using WikiPathways web services 3. PLoS ONE 4, e6447 (2009).
Danese, A. et al. Elevated inflammation levels in depressed adults with a history of childhood maltreatment 6. Arch. Gen. Psychiatry 65, 409–415 (2008).
Pace, T.W. et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 163, 1630–1633 (2006).
Attwood, B.K. et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473, 372–375 (2011).
Touma, C. et al. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior 1. Biol. Psychiatry 70, 928–936 (2011).
O'Leary, J.C. III et al. A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. PLoS ONE 6, e24840 (2011).
Gillespie, C.F. et al. Trauma exposure and stress-related disorders in inner city primary care patients. Gen. Hosp. Psychiatry 31, 505–514 (2009).
Bradley, R.G. et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch. Gen. Psychiatry 65, 190–200 (2008).
Ressler, K.J. et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470, 492–497 (2011).
Fink, L.A., Bernstein, D., Handelsman, L., Foote, J. & Lovejoy, M. Initial reliability and validity of the childhood trauma interview: a new multidimensional measure of childhood interpersonal trauma. Am. J. Psychiatry 152, 1329–1335 (1995).
Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies 1. PLoS Genet. 5, e1000529 (2009).
Birney, E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project 1. Nature 447, 799–816 (2007).
Huber, W., von, H.A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression 7. Bioinformatics 18 (suppl. 1), S96–S104 (2002).
Hagège, H. et al. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat. Protoc. 2, 1722–1733 (2007).
DeRijk, R.H., Petrides, J., Deuster, P., Gold, P.W. & Sternberg, E.M. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans 2. J. Clin. Endocrinol. Metab. 81, 228–235 (1996).
Miller, G.E., Rohleder, N., Stetler, C. & Kirschbaum, C. Clinical depression and regulation of the inflammatory response during acute stress 5. Psychosom. Med. 67, 679–687 (2005).
Sled, J.G., Zijdenbos, A.P. & Evans, A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data 4. IEEE Trans. Med. Imaging 17, 87–97 (1998).
Collins, D.L., Neelin, P., Peters, T.M. & Evans, A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18, 192–205 (1994).
Pruessner, J.C. et al. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb. Cortex 10, 433–442 (2000).
Acknowledgements
We thank T. Mletzko, K. Hafner and N.C. Gassen for their help in acquiring and interpreting data, and P. Weber for data visualization. Special thanks to A.W. Graham, A. Brown, D. Crain and D. Cross for their assistance in recruiting subjects and managing the Grady Trauma Project. This work was supported by a European Research Council starting grant (grant #281338, GxE molmech), a grant from the National Alliance for Research in Schizophrenia and Affective Disorders and a grant from the Behrens Weise Stiftung to E.B.B., a grant from the National Institute of Mental Health (MH071538) to K.J.R., and a grant from the National Institute of Mental Health (MH58922) to C.B.N., C.M.P. and C.A. have received funding from the National Institute for Health Research Biomedical Research Centre for Mental Health, Institute of Psychiatry and South London and Maudsley National Health System Foundation Trust, a Clinician Scientist Fellowship from the UK Medical Research Council (G108/603) to C.M.P., and the Commission of European Communities 7th Framework Programme Collaborative Project Grant Agreement n 22963 (Mood Inflame), also to C.M.P., C.M.H. is supported in part by Public Health Service Grant UL1 RR025008 from the Clinical and Translational Science Award program, the US National Institutes of Health, the National Center for Research Resources and by a K Award (K01 MH073698–01, Neural Substrates of Depression Risk after Child Abuse).
Author information
Authors and Affiliations
Contributions
T.K. and E.B.B. designed the experiments, performed the luciferase assays and the genetic, methylation and expression analyses, analyzed the data, and wrote the initial version of the paper. D.M. performed the RNA expression experiments and data analyses and revised the paper. M.R.-H. performed the chromatin conformation capture experiments. C.A. and C.M.P. performed the cell-culture experiments with human hippocampal progenitor cells and revised the paper. T.W.W.P. performed ex vivo glucocorticoid receptor sensitivity experiments and revised the paper. J.C.P. analyzed magnetic resonance imaging data and revised the paper. E.B.B., F.H., K.J.R., K.B.M., H.S.M., B.B., C.B.N., C.M.H. and T.R. organized sample collection and collaborations, obtained funding, supervised data analyses, and revised the paper.
Corresponding authors
Ethics declarations
Competing interests
E.B.B., T.R. and F.H. hold a patent for the use of FKBP5 in antidepressant therapy (WO 2005/054500: FKBP5: a novel target for antidepressant therapy).
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 and Supplementary Tables 1–5 (PDF 293 kb)
Rights and permissions
About this article
Cite this article
Klengel, T., Mehta, D., Anacker, C. et al. Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions. Nat Neurosci 16, 33–41 (2013). https://doi.org/10.1038/nn.3275
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3275
This article is cited by
-
Association of APP gene polymorphisms and promoter methylation with essential hypertension in Guizhou: a case–control study
Human Genomics (2023)
-
Molecular pathways of major depressive disorder converge on the synapse
Molecular Psychiatry (2023)
-
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Molecular Psychiatry (2023)
-
Methylation and expression of glucocorticoid receptor exon-1 variants and FKBP5 in teenage suicide-completers
Translational Psychiatry (2023)
-
Epigenetic differences in stress response gene FKBP5 among children with abusive vs accidental injuries
Pediatric Research (2023)